Healthcare & Life Sciences
Bonsai Biotherapeutics
Bonsai Biotherapeutics is a Healthcare & Life Sciences startup based in Sweden, most recent round Pre-Seed, 1 tracked investor.
Activepre-seed
pre-seed
Stage
1
Investors
About Bonsai Biotherapeutics
Based in Sweden, Bonsai Biotherapeutics is a startup. Its most recent tracked round is Pre-Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Bonsai Biotherapeutics develops protein-based therapeutics aimed at restoring immune tolerance to self-proteins in autoimmune diseases such as myasthenia gravis and ANCA-associated vasculitis. Its leading candidate, TOL2 for myasthenia gravis, is planned to enter placebo-controlled clinical trials in 2026.
Explore Bonsai Biotherapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.